We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Global Sepsis Diagnostics Market Driven by Rising Demand for Assays and Reagents

By LabMedica International staff writers
Posted on 03 Aug 2022
Print article
Image: Rising demand for assays and reagents is expected to boost the sepsis diagnostics market (Photo courtesy of Pexels)
Image: Rising demand for assays and reagents is expected to boost the sepsis diagnostics market (Photo courtesy of Pexels)

The global sepsis diagnostics market is projected to grow at a CAGR of close to 8% from an estimated USD 0.75 billion in 2022 to USD 1.63 billion by the end of 2032, driven mainly by a rise in regulatory approvals of essential diagnostic solutions, and demand for high levels of diagnostic precision and accuracy. Additionally, the high occurrence rates of sepsis and higher costs of stay in hospitals are expected to expand boost market growth. Also, molecular diagnostics is gaining traction due to advancements in testing technologies across the globe. Moreover, the demand for quick turnaround time and accurate results is boosting the growth of sepsis molecular diagnostics.

These are the latest findings of Fact.MR (Bangalore, India), a market research and competitive intelligence provider.

Rapid approvals of crucial sepsis diagnostics and treatment options by regulatory bodies globally, most specifically the US Food and Drug Administration, have resulted in a surge in the launch of sepsis diagnostic products. This has fueled the growth of sepsis diagnostics market. Moreover, the COVID-19 pandemic has contributed to the market growth by causing respiratory complications and sepsis of the lungs. An increase in hospitalizations due to COVID-19 has widened the growth opportunities of market players. Additionally, the high prevalence of sepsis in several high-income nations has led to the emergence of new sepsis diagnostic products in the market. Also, governments across the world are actively launching campaigns and taking initiatives to drive the adoption of modern sepsis diagnostic technologies.

Besides this, the rising prevalence of various hospital-acquired infections that are characterized by sepsis such as urinary tract infections, surgical site infection is anticipated to drive the growth of the sepsis diagnostics market. Moreover, patients suffering from septic diseases comprise a major share of hospitalizations. These factors are ultimately expected to boost the adoption of sepsis diagnostic products during the forecast period. Based on product category, the assays and reagents segment is expected to generate sales of more than USD 0.3 billion by 2032.

Geographically, the US sepsis diagnostics market is expected to register a CAGR of 7.8% between 2022 and 2032, while the Chinese sepsis diagnostics market is projected to grow at a CAGR of 7.7% to reach USD 7.5 billion by 2032. On the other hand, the sepsis diagnostics market in Germany is projected to register a CAGR of 7% during the forecast period.

Related Links:

Flocked Swab
HydraFlock and PurFlock Ultra
Gold Supplier
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Incubation & Imaging System
BD KiestraReadA
Herpes Simplex Virus Test
S3002E HSV-2

Print article


Clinical Chem.

view channel
Image: Electrochemical cells etched by laser on wooden tongue depressor measure glucose and nitrite in saliva (Photo courtesy of Analytical Chemistry)

Biosensor-Fabricated Wooden Tongue Depressor Measures Glucose and Nitrite in Saliva

Physicians often use tongue depressors to examine a patient's mouth and throat. However, it is hard to imagine that this simple wooden tool could actively assess a patient's health. This idea has led to... Read more


view channel
Image: The Atellica HEMA 570 and 580 hematology analyzers remove workflow barriers (Photo courtesy of Siemens)

Next-Gen Hematology Analyzers Eliminate Workflow Roadblocks and Achieve Fast Throughput

Hematology testing is a critical aspect of patient care, utilized to establish a patient's health baseline, track treatment progress, or guide timely modifications to care. However, increasing constraints... Read more


view channel
Image: Newly observed anti-FSP antibodies have also been found to predict immune-related adverse events (Photo courtesy of Calviri)

First Blood-Based Biomarkers Test to Predict Treatment Response in Cancer Patients

Every year worldwide, lung cancer afflicts over two million individuals and almost the same number of people succumb to the disease. This malignancy leads the charts in cancer-related mortalities, with... Read more


view channel
Image: The rapid MTB strip test for tuberculosis can identify TB patients within two hours (Photo courtesy of Chulalongkorn University)

Rapid MTB Strip Test Detects Tuberculosis in Less Than an Hour without Special Tools

Tuberculosis (TB), a highly infectious disease, continues to pose significant challenges to public health worldwide. TB is caused by a bacterium known as "Mycobacterium tuberculosis," spreading through... Read more


view channel
Image: The UNIQO 160 (CE-IVDR) advances diagnostic analysis for autoimmune diseases (Photo courtesy of EUROIMMUN)

Novel Automated IIFT System Enables Cutting-Edge Diagnostic Analysis

A newly-launched automated indirect immunofluorescence test (IIFT) system for autoimmune disease diagnostics offers an all-in-one solution to enhance the efficiency of the complete IIFT process, comprising... Read more


view channel
Electronic biosensor uses DNA aptamers for detecting biomarkers in whole blood samples (Photo courtesy of Freepik)

Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents

The absence of robust, reliable, and user-friendly bioanalytical tools for early and timely diagnosis of cardiovascular diseases, particularly sudden cardiac arrest, leads to preventable deaths and imposes... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.